Naik V, Darandale A, Pal P. Emerging Role of SGLT2 Inhibitors Beyond Glycemic Control: “Cardiovascular and Renal Benefits and Risks”. CARDIO [Internet]. 2026 Mar. 24 [cited 2026 Apr. 17];1(1):29-38. Available from: https://cdpc.gospub.com/cdpc/article/view/3